BR9714382A - 17alpha-dihydroequiline for use as a medical antioxidant - Google Patents
17alpha-dihydroequiline for use as a medical antioxidantInfo
- Publication number
- BR9714382A BR9714382A BR9714382-0A BR9714382A BR9714382A BR 9714382 A BR9714382 A BR 9714382A BR 9714382 A BR9714382 A BR 9714382A BR 9714382 A BR9714382 A BR 9714382A
- Authority
- BR
- Brazil
- Prior art keywords
- 17alpha
- dihydroequiline
- antioxidant
- medical
- medical antioxidant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Abstract
Patente de Invenção: <B>"17ALFA-DIIDROEQUILENINA PARA USO COMO UM ANTIOXIDANTE MéDICO"<D>. A presente invenção fornece um método de usar 17<244>-diidroequilenina ou um sal farmaceuticamente aceitável de éster de 17<244>-diidroequilenina-3-sulfato como um antioxidante.Invention Patent: <B> "17ALPHA-DIIDROEQUILENINE FOR USE AS A MEDICAL ANTIOXIDANT" <D>. The present invention provides a method of using 17 <244> -dihydroequilenin or a pharmaceutically acceptable salt of 17 <244> -dihydroequilenin-3-sulfate as an antioxidant.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76263496A | 1996-12-09 | 1996-12-09 | |
PCT/US1997/022155 WO1998025627A1 (en) | 1996-12-09 | 1997-12-05 | 17α-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9714382A true BR9714382A (en) | 2000-05-16 |
Family
ID=25065657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9714382-0A BR9714382A (en) | 1996-12-09 | 1997-12-05 | 17alpha-dihydroequiline for use as a medical antioxidant |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0946182A1 (en) |
JP (1) | JP2001506629A (en) |
KR (1) | KR20000069346A (en) |
CN (1) | CN1239890A (en) |
AR (1) | AR010336A1 (en) |
AU (1) | AU743519B2 (en) |
BR (1) | BR9714382A (en) |
CA (1) | CA2272089A1 (en) |
HU (1) | HUP0000570A3 (en) |
IL (1) | IL130069A0 (en) |
NZ (1) | NZ336341A (en) |
WO (1) | WO1998025627A1 (en) |
ZA (1) | ZA9711053B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271221B1 (en) * | 1996-12-10 | 2001-08-07 | American Home Products Corporation | Use of equilenin as an antioxidant |
DE10154221A1 (en) * | 2001-11-07 | 2003-05-15 | Max Delbrueck Centrum | Agent for the treatment of lesions of the nervous system |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4338314C1 (en) * | 1993-11-10 | 1995-03-30 | Jenapharm Gmbh | Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage |
-
1997
- 1997-12-05 CN CN97180446A patent/CN1239890A/en active Pending
- 1997-12-05 WO PCT/US1997/022155 patent/WO1998025627A1/en not_active Application Discontinuation
- 1997-12-05 EP EP97948610A patent/EP0946182A1/en not_active Ceased
- 1997-12-05 HU HU0000570A patent/HUP0000570A3/en unknown
- 1997-12-05 IL IL13006997A patent/IL130069A0/en unknown
- 1997-12-05 NZ NZ336341A patent/NZ336341A/en unknown
- 1997-12-05 AR ARP970105739A patent/AR010336A1/en unknown
- 1997-12-05 BR BR9714382-0A patent/BR9714382A/en not_active IP Right Cessation
- 1997-12-05 AU AU54644/98A patent/AU743519B2/en not_active Ceased
- 1997-12-05 KR KR1019997005048A patent/KR20000069346A/en not_active Application Discontinuation
- 1997-12-05 CA CA002272089A patent/CA2272089A1/en not_active Abandoned
- 1997-12-05 JP JP52680598A patent/JP2001506629A/en active Pending
- 1997-12-09 ZA ZA9711053A patent/ZA9711053B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2001506629A (en) | 2001-05-22 |
AU743519B2 (en) | 2002-01-31 |
ZA9711053B (en) | 1999-06-09 |
WO1998025627A1 (en) | 1998-06-18 |
CN1239890A (en) | 1999-12-29 |
EP0946182A1 (en) | 1999-10-06 |
IL130069A0 (en) | 2000-02-29 |
AU5464498A (en) | 1998-07-03 |
KR20000069346A (en) | 2000-11-25 |
HUP0000570A3 (en) | 2000-12-28 |
CA2272089A1 (en) | 1998-06-18 |
HUP0000570A2 (en) | 2000-10-28 |
AR010336A1 (en) | 2000-06-07 |
NZ336341A (en) | 2002-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2138691T3 (en) | PROCEDURE FOR THE OBTAINING OF DERIVATIVES OF N-ACIL-5-FLUOROCITIDINA. | |
HN1997000072A (en) | PROCEDURE FOR THE PREPARATION OF SILDENAFIL | |
AU3153097A (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
PE49195A1 (en) | PROTEINQUINASE INHIBITOR | |
BR9408407A (en) | Use of pla2 inhibitors as treatment for alzheimer's disease | |
AP9901534A0 (en) | Pharmaceutical formulations. | |
PL343156A1 (en) | Method for stabilizing pharmaceutical compositions by special use of an antioxidant | |
EA199800667A1 (en) | NEW PHENANTRIDINES | |
WO2001019829A3 (en) | Pyrazolopyrimidines as therapeutic agents | |
AU6613896A (en) | Chemical compounds | |
CU23260B7 (en) | MOXIFLOXACINE PHARMACEUTICAL PREPARATION | |
BR0012429A (en) | Formulations for il-11 | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
ATE357438T1 (en) | 1,2,4-TRIAMINOBENZENE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | |
BR9813817A (en) | Hemiasterline analogs | |
GB9907571D0 (en) | Compounds | |
ES2180175T3 (en) | USE OF AN INHIBITING SUBSTANCE FOR THE IMPROVEMENT OF THE NEURONAL REGENERATION. | |
BR9713176A (en) | Amorphous benzothiophenes, methods of preparation and methods of use | |
WO2003004517A3 (en) | Peyers's patch and/or m-celle targeting ligands | |
BR9814495A (en) | Compound, process to prepare it, use of it, pharmaceutical composition, and, process | |
EP1073447A4 (en) | N1-modified glycopeptides | |
BR9714382A (en) | 17alpha-dihydroequiline for use as a medical antioxidant | |
NO20005548L (en) | Mykobakterieinhibitorer | |
BR9714384A (en) | Use of equeilenina as an antioxidant | |
ES2174150T3 (en) | PROCEDURE FOR OBTAINING 4-HYDROXIANILINS. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B25D | Requested change of name of applicant approved | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 3A E 7A ANUIDADES. |